Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ImmunityBio (IBRX) Interest Coverage Ratio: 2016-2025

Historic Interest Coverage Ratio for ImmunityBio (IBRX) over the last 7 years, with Sep 2025 value amounting to -3.65.

  • ImmunityBio's Interest Coverage Ratio fell 33.23% to -3.65 in Q3 2025 from the same period last year, while for Sep 2025 it was -3.61, marking a year-over-year decrease of 20.84%. This contributed to the annual value of -3.00 for FY2024, which is 6.83% down from last year.
  • Per ImmunityBio's latest filing, its Interest Coverage Ratio stood at -3.65 for Q3 2025, which was up 20.85% from -4.61 recorded in Q2 2025.
  • Over the past 5 years, ImmunityBio's Interest Coverage Ratio peaked at -2.29 during Q3 2023, and registered a low of -27.23 during Q1 2021.
  • Moreover, its 3-year median value for Interest Coverage Ratio was -3.23 (2024), whereas its average is -3.25.
  • In the last 5 years, ImmunityBio's Interest Coverage Ratio slumped by 62.12% in 2021 and then spiked by 83.16% in 2022.
  • ImmunityBio's Interest Coverage Ratio (Quarterly) stood at -17.66 in 2021, then skyrocketed by 83.16% to -2.97 in 2022, then grew by 9.84% to -2.68 in 2023, then increased by 0.79% to -2.66 in 2024, then plummeted by 33.23% to -3.65 in 2025.
  • Its Interest Coverage Ratio was -3.65 in Q3 2025, compared to -4.61 in Q2 2025 and -4.21 in Q1 2025.